A reduced transcriptional transactivation response to RA was previously demonstrated for RARA constructs encoding p.Gly289Arg in the context of somatically acquired mutation in acute promyelocytic leukemia,79 but the pathogenic mechanism in a developmental context requires elucidation. This evidence concerns the gene RARA and acute promyelocytic leukemia.